5-Hydroxymethylcytosine (5-hmC) loss is a marker of malignancy in biliary neoplasms.
Gonzalez-Mancera MS, Siref A, Kosari K, Nissen N, Gaddam S, Hendifar A, Osipov A, Waters K, Hutchings D, Guindi M, Larson BK.
Gonzalez-Mancera MS, et al. Among authors: siref a.
Am J Clin Pathol. 2024 Jul 5;162(1):41-50. doi: 10.1093/ajcp/aqae001.
Am J Clin Pathol. 2024.
PMID: 38345293